Antiphospholipid syndrome: the need for new international classification criteria
- 17 March 2021
- journal article
- other
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 17 (4) , 385-394
Abstract
Introduction: As soon as the association of lupus anticoagulant (LAC) and anticardiolipin antibodies (aCL) with thrombosis and miscarriages was described in the 1980s, the definition of the antiphospholipid syndrome (APS) became a need. Early descriptions of the disease by members of the Graham Hughes team included broad categories and unexplained laboratory inclusions. Over time, new clinical and experimental data refined the criteria, especially the obstetric manifestations, as well as the laboratory criteria. Areas covered: The authors performed a review of the literature using the PubMed database, and the following keywords were used: ‘antiphospholipid antibody’, ‘antiphospholipid syndrome’, and ‘criteria of antiphospholipid’. The history of antiphospholipid criteria, clinical and experimental advancements, and other expert opinions were included in this paper. Expert opinion: It has been 14 years since an international congress on antiphospholipid antibodies has generated new classification based on the recent extensive research performed in the field. Currently, there is a need to update the international APS classification taking into consideration the inclusion of new clinical criteria such as aPL-related nephropathy as well as new standardized antibody specificities (e.g., anti-phosphatidylserine/prothrombin antibodies) with the adoption of a standardized scoring system that can stratify APS patients.Keywords
This publication has 76 references indexed in Scilit:
- Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profileJournal of Thrombosis and Haemostasis, 2013
- Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA CohortFrontiers in Neurology, 2012
- History of the Antiphospholipid SyndromeRevista Colombiana de Reumatología, 2009
- Human lupus autoantibodies against NMDA receptors mediate cognitive impairmentProceedings of the National Academy of Sciences, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Consensus guidelines on anti-cardiolipin antibody testing and reportingPathology, 2004
- Choline Release and Inhibition of Phosphatidylcholine Synthesis Precede Excitotoxic Neuronal Death but Not Neurotoxicity Induced by Serum DeprivationJournal of Biological Chemistry, 2000
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- SYNDROME OF THE BLACK SWANRheumatology, 1987
- Connective tissue disease and the skinClinical and Experimental Dermatology, 1984